BREAKING: Hollister Biosciences Signs Letter of Intent to Acquire Venom Extracts With $16.4 Million In Revenue And $2.48 Million EBITDA

HIGHLY ACCRETIVE $20,000,000 ACQUISITION

• Venom is one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products
• Venom reported having generated CDN$ 16.4 million in revenue and CDN$ 2.48 million in EBIDTA from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges

Read Today's Release